Alpha and Gamma Interferons' Effects on Cortical and Hippocampal Neurons: Microiontophoretic Application and Single Cell Recording

References

• Aguet M. High-affinity binding of I125-labeled mouse interferon to specific cell surface receptor. Nature (London) 1980; 284: 459–461
   PubMed Web of Science ®Google Scholar
• Balkwill I. F. Interferons as cell regulatory molecules. Cancer Immunology and Immunotherapy 1979; 7: 7–14
   Web of Science ®Google Scholar
• Blacock J. E., Smith E. M. Structure and function of interferon (IFN) and neuroendocrine hormones. The biology of the interferon system, E. DeMaeyer, G. Galasso, H. Schellekans. Elsevier North Holland Biomedical Press, Amsterdam 1981a; 93–99
   Google Scholar
• Blalock J. E., Smith E. M. Human leukocyte interferon (HuIFN-α): potent endorphin-like opioid activity. Biochemical, Biophysical Research Communication 1981b; 101: 472–478
   PubMed Web of Science ®Google Scholar
• Blalock J. E., Stanton J. D. Common pathways of interferon and hormonal action. Nature (London) 1980; 283: 406–408
   PubMedGoogle Scholar
• Calvet M. C., Gresser I. Interferon enhances the excitability of cultured neurons. Nature (London) 1979; 278: 558–560
   PubMedGoogle Scholar
• Dafny N. Electrophysiological properties of caudate neurons following substantia nigra, motor cortex, and amygdaloid nuclear complex stimulation of the rat. Applied Neurophysiology 1975; 38: 259–272
   Google Scholar
• Dafny N. Interferon modifies EEG and EEG-like activity recorded from sensory, motor, and limbic system structures in freely behaving rats. Neurotoxicology 1983; 4: 235–240
   PubMed Web of Science ®Google Scholar
• Friedman R. M. Interferon binding: the first step in establishment of antiviral activity. Science 1967; 156: 1760–1761
   PubMed Web of Science ®Google Scholar
• Friedman R. M., Pastan I. Interferon and cyclic -3'5″-adenosine monophosphate: potentiation of antiviral activity. Biochemical and Biophysical Research Communications 1969; 36: 735–740
   PubMed Web of Science ®Google Scholar
• Gisler R. H., Lindvahl P., Gresser I. Effect of interferon on antibody synthesis in vitro. Journal of Immunology 1974; 113: 438–444
   PubMed Web of Science ®Google Scholar
• Goeddel D. V., Yelverton E., Ullrich A., et al. Human leukocyte interferon produced by E. coli is biologically active. Nature 1980; 287: 411–416
   PubMed Web of Science ®Google Scholar
• Gresser I. Antitumor effects of interferon in cancer. Cancer: A comprehensive treatise, F. Becker. Plenum Press, New York 1977; Vol. 5: 521–571
   Google Scholar
• Gresser I. Effects of interferon in vivo, In The biology of the interferon system. E. DeMaeyer, E. Galasso, H. Schellekens. Elsevier/North Holland Biomedical Press, Amsterdam 1981; 141–147
   Google Scholar
• Gutterman J. V., Fine S., Quesada J., Horning S. J., Levine J. F., Alexanian R., Bernhardt L., Kramer M., Spiegel H., Colburn W., Trown P., Merigan T., Dziewanowski Z. Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance and biologic effects in cancer patients. Annals of International Medicine 1982; 96: 549–556
   PubMed Web of Science ®Google Scholar
• Isaacs A., Lindenmann J. Virus interference. I. The Interferon. Proceedings Society Section B 1957; 147: 258–267
   Google Scholar
• Kohn L. D. Relationship in the structure and function of cell surface receptors for glycoprotein hormones, bacterial toxins and interferon. Annals Rept. Medicinal Chemistry 1977; 21: 221–222
   Google Scholar
• Konig J. F. R., Klippel R. A. The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem. R. E. Krieger Publishing Co., New York 1970
   Google Scholar
• Lindahl P., Leary P., Gresser I. Interferon inhibits DNS synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogenic cells. Nature (New Biology) 1972; 237: 120–121
   Google Scholar
• Lindahl P., Leary P., Gresser I. Enhancement by interferon of the expression of surface antigens on murine leukemia L1210 cells. Proceeding National Academy of Science, USA 1970; 70: 2785–2788
   Google Scholar
• Maeda S., McCandliss R., Gross M., Sloma A., Familetti P. C., Tabor J. M., Evinger M., Levy W. P., Pestka S. Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon. Proceedings of National Academy of Science, USA 1980; 77: 7010–7013
   PubMedGoogle Scholar
• Pollard R. B. Usages of interferon and interferon inducers in man: the second half of 1980. Medical Biology 1980; 59: 69–76
   Google Scholar
• Priestman T. J. Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease. Lancet 1980; 2: 113–118
   Google Scholar
• Satoh M., Zieglgansberger W., Herz A. Actions of opiates upon single unit activity in the cortex of naive and tolerant rats. Brain Research 1976; 115: 99–110
   Google Scholar
• Scott G. M., Secher D. S., Flowers D., Bate J., Cantell K., Tyrrell D. A. J. Toxicity of interferon. British Medical Journal 1981; 282: 1345–1348
   PubMed Web of Science ®Google Scholar
• Smalley R. V., Oldham R. K. Interferon as a biological response modifying agent in clinical trials. Journal of Biological Response Modifiers 1983; 2: 401–408
   PubMedGoogle Scholar
• Smedley H. M., Kratrak M., Sikon K., Wheeler T. Neurological effects of recombinant human interferon. British Medical Journal 1983; 286: 262–264
   PubMed Web of Science ®Google Scholar
• Smith E. M., Blalock J. E. Human leukocyte production of corticotropin and endorphin-like substances: Association with leukocyte interferon. Proceedings National Academy of Science 1981; 78: 7530–7534
   PubMed Web of Science ®Google Scholar
• Sonnenfeld G. Contradictory results in interferon research. Survey Immunology Research 1984; 3: 198–201
   Google Scholar